The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 851.40
Bid: 853.00
Ask: 853.40
Change: 2.80 (0.33%)
Spread: 0.40 (0.047%)
Open: 852.60
High: 854.80
Low: 849.20
Prev. Close: 848.60
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Update

21 May 2019 16:50

RNS Number : 7567Z
Informa PLC
21 May 2019
 

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC

21 May 2019

 

Board Update

 

London: Informa (LSE: INF.L), the International Exhibitions, Events, Information Services and Scholarly Publishing Group, today confirmed that Cindy Rose and David Wei have chosen not to stand for re-election as Non-Executive Directors at the Group's upcoming AGM on 24 May and will be stepping down from the Board of Informa effective from the end of the AGM.

Cindy Rose joined Informa in 2013 and having completed six years as a Non-Executive Director has chosen not to seek another term.

David Wei joined the Board in 2018 following the Combination with UBM. As Informa approaches the one-year anniversary of the Combination and successful completion of the Accelerated Integration Plan, David has also decided not to seek re-election, allowing him to focus on his other professional commitments.

The Group has engaged an International Search firm to assist with the search for a new Non-Executive Director and further announcements will be made in due course.

Derek Mapp, Chairman, Informa PLC, said:

"On behalf of Informa, I'd like to thank both Cindy and David for their valuable contributions to the Company. Cindy has served on the Board for six years, providing considerable insight and counsel during a time when the Group has grown and expanded significantly, whilst David's tenure over the last year has helped ensure a smooth and effective combination with UBM. We wish them both the best in the future."

This announcement has been made in accordance with Listing Rule 9.6.11 R (2). Both Cindy and David will cease to be Directors at the conclusion of the AGM and Resolutions 10 and 5, which relate to their re-election, will be withdrawn. This does not affect the validity of any proxy votes already submitted. Both Directors will receive their annual Non-Executive Director fees on a pro-rata basis up until this time.

Enquiries

 

Informa PLC

Rupert Hopley, Company Secretary

Richard Menzies-Gow, Director of IR & Comms

 

+44 (0)20 7017 5000

+44 (0)20 3377 3445

Teneo Strategy

Tim Burt / Zoe Watt

 

+44 (0)20 7240 2486

 

 

Notes to Editors

Informa PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group with annual revenues approaching £3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASEWFIFFUSELI
Date   Source Headline
24th Mar 20227:00 amRNSInforma Share Buyback Programme
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSInforma Share Buyback Programme
21st Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSInforma Share Buyback Programme
15th Mar 20225:53 pmRNSHolding(s) in Company
15th Mar 20225:35 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNS2021 Full Year Results Statement
15th Mar 20227:00 amRNSHolding(s) in Company
8th Mar 20227:00 amRNSInforma Share Buyback Programme
7th Mar 20227:00 amRNSInforma Share Buyback Programme
4th Mar 20227:00 amRNSInforma Share Buyback Programme
3rd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSTotal Voting Rights
1st Mar 20227:00 amRNSInforma Share Buyback Programme
28th Feb 20227:00 amRNSInforma Share Buyback Programme
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSInforma Share Buyback Programme
23rd Feb 20227:00 amRNSInforma Share Buyback Programme
22nd Feb 20227:00 amRNSInforma Share Buyback Programme
21st Feb 20225:34 pmRNSHolding(s) in Company
21st Feb 20225:29 pmRNSHolding(s) in Company
21st Feb 20227:55 amRNSInforma Share Buyback Programme
18th Feb 20227:00 amRNSInforma Share Buyback Programme
17th Feb 20227:00 amRNSInforma Share Buyback Programme
16th Feb 202211:18 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSInforma Share Buyback Programme
15th Feb 20227:00 amRNSInforma Share Buyback Programme
10th Feb 20228:10 amRNSDivestment of Pharma Intelligence for £1.9bn
4th Feb 20226:03 pmRNSBlock listing Interim Review
4th Feb 20224:03 pmRNSNotice of Results
1st Feb 20224:17 pmRNSHolding(s) in Company
20th Jan 20224:58 pmRNSHolding(s) in Company
13th Jan 20225:40 pmRNSBoard Update
13th Jan 20227:00 amRNSHolding(s) in Company
12th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20225:52 pmRNSHolding(s) in Company
12th Jan 20225:51 pmRNSHolding(s) in Company
17th Dec 20212:16 pmRNSDirector/PDMR Shareholding
14th Dec 202110:53 amRNSHolding(s) in Company
14th Dec 202110:19 amRNSDirector/PDMR Shareholding
7th Dec 202112:00 pmRNSCapital Markets Day - Growth Acceleration Plan II
26th Nov 20213:32 pmRNSHolding(s) in Company
26th Nov 20213:27 pmRNSHolding(s) in Company
17th Nov 20217:00 amRNSTrading Statement & Board Update
1st Oct 20217:00 amRNSBoard Update
5th Aug 20216:19 pmRNSBlock listing Interim Review
5th Aug 20216:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.